Seropositivity to Burkholderia pseudomallei does not reflect the development of cell-mediated immunity

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 102, Issue SUPPL. 1, 2008, Pages

  Lazzaroni, Sharon M ^a   Barnes, Jodie L ^a   Williams, Natasha L ^a   Govan, Brenda L ^a   Norton, Robert E ^a,b   LaBrooy, Justin T ^a   Ketheesan, Natkunam ^a  

^a JAMES COOK UNIVERSITY   (Australia)

^b QUEENSLAND HEALTH   (Australia)

Author keywords

Antibodies; Burkholderia pseudomallei; Cell mediated immunity; Indirect haemagglutination assay; Melioidosis; Seroprevalence

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; CYTOKINE;

ADULT; ANTIBODY TITER; ARTICLE; AUSTRALIA; BURKHOLDERIA PSEUDOMALLEI; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DONOR; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HEMAGGLUTINATION TEST; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; MELIOIDOSIS; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BURKHOLDERIA PSEUDOMALLEI; CELL PROLIFERATION; CYTOKINES; FEMALE; HEMAGGLUTINATION TESTS; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; MALE; MELIOIDOSIS; MIDDLE AGED;

BURKHOLDERIA PSEUDOMALLEI;

EID: 58049181722     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(08)70018-X     Document Type: Article

References (23)

1. Cheng A.C., and Currie B.J. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 18 (2005) 383-416
2. Peacock S.J. Melioidosis. Curr Opin Infect Dis 19 (2006) 421-428
3. Barnes J.L., Warner J., Melrose W., Durrheim D., Speare R., Reeder J.C., et al. Adaptive immunity in melioidosis: a possible role for T cells in determining outcome of infection with Burkholderia pseudomallei. Clin Immunol 113 (2004) 22-28
4. Ketheesan N., Barnes J.L., Ulett G.C., VanGessel H.J., Norton R.E., Hirst R.G., et al. Demonstration of a cell-mediated immune response in melioidosis. J Infect Dis 186 (2002) 286-289
5. Barnes J.L., and Ketheesan N. Development of protective immunity in a murine model of melioidosis is influenced by the source of Burkholderia pseudomallei antigens. Immunol Cell Biol 85 (2007) 551-557
6. Haque A., Chu K., Easton A., Stevens M.P., Galyov E.E., Atkins T., et al. A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins. J Infect Dis 194 (2006) 1241-1248
7. Haque A., Easton A., Smith D., O'Garra A., Van Rooijen N., Lertmemongkolchai G., et al. Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection. J Infect Dis 193 (2006) 370-379
8. Ashdown L.R., and Guard R.W. The prevalence of human melioidosis in Northern Queensland. Am J Trop Med Hyg 33 (1984) 474-478
9. Gilmore G., Barnes J., Ketheesan N., and Norton R. A comparison of the use of Burkholderia pseudomallei, B. thailandensis and B. cepacia as antigens in the indirect haemagglutination assay for melioidosis. Clin Vaccine Immunol 14 (2007) 1529-1531
10. Cheng A.C., O'Brien M., Freeman K., Lum G., and Currie B.J. Indirect hemagglutination assay in patients with melioidosis in northern Australia. Am J Trop Med Hyg 74 (2006) 330-334
11. Ashdown L.R., Johnson R.W., Koehler J.M., and Cooney C.A. Enzymelinked immunosorbent assay for the diagnosis of clinical and subclinical melioidosis. J Infect Dis 160 (1989) 253-260
12. Naigowit P., Maneeboonyoung W., Wongroonsub P., Chaowagul V., and Kanai K. Serosurveillance for Pseudomonas pseudomallei infection in Thailand. Jpn J Med Sci Biol 45 (1992) 215-230
13. Malczewski A.B., Oman K.M., Norton R.E., and Ketheesan N. Clinical presentation of melioidosis in Queensland, Australia. Trans R Soc Trop Med Hyg 99 (2005) 856-860
14. Armstrong P.K., Anstey N.M., Kelly P.M., Currie B.J., Martins N., Dasari P., et al. Seroprevalence of Burkholderia pseudomallei in East Timorese refugees: implications for healthcare in East Timor. Southeast Asian J Trop Med Public Health 36 (2005) 1496-1502
15. Wuthiekanun V., Langa S., Swaddiwudhipong W., Jedsada-panpong W., Kaengnet Y., Chierakul W., et al. Short report: Melioidosis in Myanmar: forgotten but not gone?. Am J Trop Med Hyg 75 (2006) 945-946
16. Chantratita N., Wuthiekanun V., Thanwisai A., Limmathurot-sakul D., Cheng A.C., Chierakul W., et al. Accuracy of enzymelinked immunosorbent assay using crude and purified antigens for serodiagnosis of melioidosis. Clin Vaccine Immunol 14 (2007) 110-113
17. Druar C., Yu F., Barnes J.L., Okinaka R.T., Chantratita N., Beg S., et al. Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents. FEMS Immunol Med Microbiol 52 (2008) 78-87
18. Ulett G.C., Labrooy J.T., Currie B.J., Barnes J.L., and Ketheesan N. A model of immunity to Burkholderia pseudomallei: unique responses following immunization and acute lethal infection. Microbes Infect 7 (2005) 1263-1275
19. Barnes J.L., and Ketheesan N. Route of infection in melioidosis. Emerg Infect Dis 11 (2005) 638-639
20. Andersen P., Doherty T.M., Pai M., and Weldingh K. The prognosis of latent tuberculosis: can disease be predicted?. Trends Mol Med 13 (2007) 175-182
21. Arend S.M., Andersen P., van Meijgaarden K.E., Skjot R.L., Subronto Y.W., van Dissel J.T., et al. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J Infect Dis 181 (2000) 1850-1854
22. Arend S.M., Geluk A., van Meijgaarden K.E., van Dissel J.T., Theisen M., Andersen P., et al. Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides. Infect Immun 68 (2000) 3314-3321
23. Dillon D.C., Alderson M.R., Day C.H., Bement T., Campos-Neto A., Skeiky Y.A., et al. Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG. J Clin Microbiol 38 (2000) 3285-3290